Pharmaceutical Research

Study reports urinary incontinence in 29% of young women taking antipsychotic drugs compared to 13% of age-matched controls.

The effects can impact cognitive development and long-term brain function, with a high risk of progressive difficulties as patients age.

Study compares the risk of nonarteritic anterior ischemic optic neuropathy (NAION) in new users of semaglutide versus sodium-glucose cotransporter 2 (SGLT2) inhibitors.

Study clarifies whether long-term use of proton pump inhibitors is associated with an increased risk of gastric adenocarcinoma.

The results are striking: 80% of lung cancer patients responded to treatment, almost double the rates usually observed. And that's not the only type of cancer the study looked at.

Mummy powder was a popular treatment, way back in the day.

Study compares the effectiveness of SGLT2i and GLP-1RA treatment for acute and chronic kidney outcomes in patients with type 2 diabetes.

Systematic review and meta-analyses of real-world evidence examines the association of SGLT2 inhibitors and the risk of infections in patients with type 2 diabetes.